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summary
Background: Oil refinery workers are exposed to several well-established carcinogens and working in this type of 
industry has been classified by IARC as probable carcinogen to humans (Group 2A). Objectives: To examine the 
mortality experience of workers employed in four Italian oil refineries. Methods: The cohort included 5112 male 
workers ever employed between 1949 and 2011. The average follow-up period was 49 years. Standardized mortal-
ity ratios (SMR) and 95% Confidence Intervals (CI) were calculated using as reference age-gender-calendar specific 
regional rates. Analyses by duration of employment and latency were performed. Results: In the whole cohort, pleural 
cancer (6 deaths, SMR 1.59; 95% CI 0.71-3.53), brain cancer (14 deaths, SMR 1.47; 95% CI 0.87-2.49) and lym-
phatic leukemia (LL) (8 deaths, SMR 1.81; 95% CI 0.91-3.62) showed increased risks. All pleural cancers occurred 
after 10 years of latency and the highest risk was observed among workers with duration ≥20 years; the brain cancer 
excess was confined in the shortest duration and latency. The LL (and chronic lymphatic leukemia in particular) excess 
regarded workers with latency and duration longer than 20 years. Four deaths from acute myeloid leukemia (AML) 
were observed and all occurred after 20 years of latency (SMR 1.55, 95% CI 0.58-4.12); a two-fold-increased risk 
was observed in the longest duration. No increased risk for skin cancer has been observed in our study population. Con-
clusion: Our findings are consistent with recent evidence of an increased mortality from pleural and hematopoietic 
malignancies (AML and LL) among oil refinery workers. However, the lack of individual quantitative exposure data 
and the small number of observed events prevent the identification of the possible causal role of individual chemicals, 
including benzene, especially at the current very low exposure levels.
riassunto
«Rischio di cancro nei lavoratori addetti alla raffinazione di petrolio: uno studio di mortalità in impianti ital-
iani». Introduzione: I lavoratori dell ’industria petrolchimica sono esposti a numerosi noti agenti cancerogeni e l ’at-
tività lavorativa in questo settore è stata definita come probabilmente cancerogena per l ’uomo dalla IARC (Gruppo 
2A). Obiettivo: Studiare la mortalità causa specifica nei lavoratori di quattro raffinerie italiane. Metodi: La coorte 
 open access www.lamedicinadellavoro.it
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introduction
The oil refinery industry employs hundreds of 
thousands of workers worldwide with exposure to 
several well-established human carcinogens such as 
benzene, untreated or mildly treated mineral oils, 
polycyclic aromatic compounds, several metals (in-
cluding arsenic, lead, chromium, nickel) and asbes-
tos. In 1989, the International Agency for Research 
on Cancer (IARC), evaluated working in petrole-
um refineries as “probably carcinogenic to humans 
(Group 2A)”. This limited evidence applied to skin 
cancer and leukemia (7).
Subsequent to IARC evaluation, several epidemi-
ological studies focused on cancer mortality among 
petrolchemical workers and reported increased risks 
for additional cancer sites. An extensive systematic 
review of those studies was conducted by Wong and 
Raabe separately for solid tumors (23) and lym-
phohemopoietic cancers (16, 24). Analyzing about 
350,000 workers from US, Canada, Europe and 
Australia, the authors did not observe an increase 
in mortality from specific cancer sites with the only 
possible exception of skin cancer (pooled RR=1.10, 
95% CI 0.99-1.22).   
Benzene could contribute to increase cancer risk 
in the oil refinery industry. Benzene occurs naturally 
at small concentrations in gasoline and is also added 
to unleaded gasoline for its anti-knock properties. 
In 2009, IARC updated its evaluation of benzene 
carcinogenicity (1, 8): in addition to the well-known 
association with acute myeloid leukemia (AML), 
the IARC Working Group examined the results of 
numerous epidemiological studies and concluded 
for a limited evidence of an increase in risk of acute 
and chronic lymphatic leukemia (ALL, CLL), non-
Hodgkin lymphoma (NHL) and multiple myeloma 
(MM). 
Following the updated IARC classification of 
benzene, a few studies investigated in more detail 
the risk of hematopoietic malignancies among oil 
refinery workers, focusing on the different subtypes, 
with conflicting results. In 2011, an extensive meta-
analysis of occupational cohort studies (21) reported 
evidence for an association between occupational 
exposure to benzene and risk of MM, ALL, and 
CLL, which was more pronounced in follow-up 
studies starting after 1970 and in studies reporting 
an elevated risk of AML (considered as a proxy of 
good methodological quality, due to its well-known 
association with benzene exposure). On the other 
hand, the association with risk of non Hodgkin’s 
lymphoma (NHL) was unclear. 
Khalade et al (11) in a meta-analysis of 15 stud-
ies found evidence of an increased risk of AML and 
CLL, but no association between benzene exposure 
and CML risk. 
Koh and colleagues (12) investigated the mor-
tality of a large cohort of workers employed at one 
refinery and six petrochemical plants in Korea. In-
allo studio è composta da 5112 lavoratori maschi, impiegati tra il 1949 e il 2011, seguiti nel tempo per un follow-up 
medio pari a 49 anni. Sono stati calcolati i Rapporti Standardizzati di Mortalità (SMR) con i relativi Intervalli 
di Confidenza (IC) al 95% utilizzando tassi regionali specifici per età e genere. È stata poi effettuata l ’analisi per 
latenza e durata dell ’esposizione per selezionate cause di morte. Risultati: Nell ’intera coorte si è osservata una mor-
talità aumentata per mesotelioma pleurico (6 decessi, SMR 1.59; IC 95% 0.71-3.53), tumore al cervello (14 decessi, 
SMR 1.47; IC 95% 0.87-2.49) e leucemie linfatiche (LL) (8 decessi, SMR 1.81; IC 95% 0.91-3.62). Tutte le morti 
per tumore della pleura si sono verificate dopo oltre 10 anni di latenza e in lavoratori con durata dell ’esposizione ≥20 
anni, mentre quelle per tumori cerebrali si sono verificati in lavoratori con latenza e durata dell ’esposizione <10 anni. 
I casi di LL (di tipo cronico in particolare) hanno riguardato lavoratori con latenza e durata esposizione ≥20 anni. 
Sono stati osservati 4 casi fatali di leucemia mieloide acuta (LMA), tutti nel gruppo con latenza ≥20 anni (SMR 
1.55, IC 95% 0.58-4.12); un incremento di due volte nella mortalità è emerso tra i lavoratori con oltre 20 anni di 
durata dell ’esposizione. Non è stato osservato nessun aumento di rischio per tumore alla cute. Conclusione: I nostri 
risultati sono coerenti con le recenti evidenze di un aumento di mortalità per mesotelioma e tumori emopoietici (LL 
e LMA) nei lavoratori dell ’industria petrolchimica. Tuttavia, il ridotto numero di casi osservati e la scarsità di dati 
quantitativi di esposizione non permettono di identificare in modo univoco il ruolo dell ’esposizione a benzene nel 
determinare il rischio, soprattutto alle attuali  basse dosi.
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creased risks for leukemia and lymphohematopoi-
etic cancers were observed in production workers. 
An increased incidence of NHL was observed in an 
Italian cohort study of petrochemical workers (3): 
the excess was mainly concentrated in workers of 
the vinyl chloride monomer production plant.
A pooled analysis of three case-control studies 
with well documented low exposure to benzene, 
failed to show a dose-response relationship for both 
AML and CLL, suggesting that previous evidences 
might have been related to higher exposures or to 
more complex exposure-patterns (17).
A few studies focused on asbestos exposure 
among petrochemical workers, and showed an in-
creased risk of pleural mesothelioma, particularly 
among maintenance workers (6, 13, 15, 18, 20). Pos-
itive associations were found in two large cohorts in 
Canada (35,000 workers, SMR=8.6 among main-
tenance workers) (13) and USA (10,000 workers, 
SMR for maintenance workers=4.7) (20). Conflict-
ing findings have been found among petrochemical 
workers in Italy, and in particular among mainte-
nance workers. Maintenance activities often involve 
direct contact with asbestos in Italian oil refineries. 
(3, 6, 15).
To contribute to quantify occupational cancer 
risk in oil refinery workers, we conducted a large 
mortality cohort study by pooling four Italians co-
horts with more than 5,000 workers followed up for 
a long period of time. 
In this paper, we present results on the mortal-
ity experience of the whole cohort, which includes 
a plant that was previously investigated (2, 5) and 
whose follow-up has now been extended. 
methods
Study population
The overall cohort included 5112 male workers 
ever employed between 1949 and 2011 in four oil 
refineries in Northern (Milano, Cremona) and Cen-
tral Italy (Cagliari, Rome). 
Information on date of birth, residence, date of 
hire and duration of employment was abstracted for 
each study subject from the companies’ personnel 
records.
Vital status was ascertained through the vital sta-
tistic offices of the town of the subjects’ last resi-
dence. For deceased subjects, death certificates were 
obtained and coded according to standard rules fol-
lowing the International Classification of Diseases 
in use at the time of death and then converted to the 
ICD-9 revision codes.
Cohort members contributed to the person-years 
from the beginning of employment in the plant un-
til exit from the study (because of death, emigration, 
or loss to follow-up), or until the end of the study 
period. 
Statistical Analysis
We calculated cause-specific Standardized Mor-
tality Ratios (SMR), and 95% confidence intervals 
(CI), as the ratio of observed and expected deaths 
using the mortality rates specific by age, gender, and 
calendar years (1970-2012) of the regions where 
the plants were located as reference. Italian rates 
were used for the years 1949-1969, when regional 
rates were unavailable. We explored cause-specific 
mortality by duration of employment (0-9 10-19, 
20 or more years), time since first employment (i.e 
latency: 0-9, 10-19, 20 or more years) and period of 
employment (≤1969, 1970-1979, ≥1980).
Duration of employment was lagged 10 years for 
all plants (5), to overcome the lack of information 
about occupational history between 1982 and 1992 
in one plant (Milano) in the last 10 years before ces-
sation of activity.
We used Poisson regression modeling with an in-
ternal reference in the analysis of duration and latency.
results
The main characteristics of the four cohorts are 
reported in table 1. Subjects contributed to a total of 
143,303 person years. The average follow-up length 
was 49 years. Vital status ascertainment was suc-
cessful for 98.5% of the workers. Cause of death was 
unknown for 66 (1.3%) subjects; we included these 
deaths in the overall mortality but not in the analy-
sis of cause-specific mortality. 
Mortality by specific cause of death is reported in 
table 2. Overall mortality was lower than expected, 
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mainly because of a marked reduction of mortality 
from cardiovascular, respiratory, digestive and genito-
urinary diseases. All cancer mortality was also lower 
than expected. As regard specific cancer deaths, we 
did not observe any significant excess risk; deaths 
were slightly above the expectation for pleural can-
Table 1 - Main characteristics of the four sub-cohorts under investigation
Oil refinery plant Number of Period of Follow-up period,   Deaths  Lost to follow-up
 subjects employment mean duration N (%) N (%)
Milano 1583 1949-1982 1949-2006, 57Y 670   (42%) 21 (1.3%)
Cremona   903 1961-2010 1961-2011, 50Y 196   (22%) 22 (2.6%)
Roma   676 1965-1982 1965-2006, 41Y 142   (21%)   7 (1.0%)
Cagliari 1950 1964-2011 1964-2012, 48Y 152 (8%) 25 (1.3%)
Total 5112   (49 years) 160   (23%) 75 (1.5%)
Table 2 - Mortality results by specific cause of death
Cause of death (ICD-9 code) Deaths SMR 95%CI
All causes (000-989) 1160 0.81 0.77-0.86
All cancers (140-239) 454 0.87 0.79-0.95
Digestive tract cancers (150-159) 153 0.82 0.70-0.96
       Stomach (151) 41 0.85 0.62-1.16
       Colon (153) 28 0.91 0.63-1.32
       Rectum (154) 13 0.96 0.56-1.66
       Liver (155) 30 0.71 0.50-1.02
       Pancreas (157) 22 0.97 0.64-1.48
Lung (162) 139 0.86 0.72-1.01
Pleural (163)  6 1.59 0.71-3.53
Skin (172-173) 3 0.55 0.18-1.70
Prostate (185) 20 0.75 0.48-1.16
Bladder (188) 17 0.86 0.54-1.39
Brain (191,225) 14 1.47 0.87-2.49
Lymphatic and Hematopoietic (200-208) 41 1.16 0.86-1.58
    Lymphoma (200,202) 17 1.13 0.70-1.82
       Hodgkin’s Disease (201) 4 1.35 0.51-3.60
       non-Hodgkin’s Lymphoma (202) 13 1.08 0.62-1.85
    Multiple Myeloma (203) 3 0.51 0.16-1.57
    Leukemia (204,208) 21 1.41 0.92-2.17
       Myeloid leukemia 8 1.28 0.64-2.56
       Acute myeloid leukemia (AML) 4 1.23 0.46-3.27
       Chronic myeloid leukemia (CML) 3 1.33 0.43-4.10
    Lymphatic leukemia 8 1.81 0.90-3.62
       Chronic lymphatic leukemia   (CLL) 6 1.63 0.73-3.62
       Acute lymphatic leukemia (ALL) 0 - -
Cardiovascular diseases (390-458) 339 0.70 0.63-0.78
Respiratory diseases (460-519) 49 0.59 0.44-0.78
Digestive tract diseases (520-579) 57 0.55 0.42-0.71
Genito-urinary tract diseases (580-629) 10 0.62 0.33-1.15
Accidents (800-999) 72 0.71 0.57-0.90
SMR: Standardized Mortality Ratio; CI: Confidence interval 
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cer (6 deaths, SMR=1.59, 95% CI 0.71-3.53), and 
brain cancer (14 deaths, SMR=1.47, 95% CI 0.89-
2.49). We did not observe an increase in mortality 
from lympohemopoietic neoplasms; deaths from 
lymphatic leukemia (LL¸ 8 deaths, SMR=1.81, 95% 
CI 0.91-3.62), myeloid leukemia (ML, 8 deaths, 
SMR=1.28, 95% CI 0.64-2.56), and Hodgkin Lym-
phoma (HL, 4 deaths, SMR=1.35, 95% CI 0.51-
3.60) were non significantly above the expectation.
Table 3 and 4 show results by time since first em-
ployment and duration of employment for cancers 
with at least 4 deaths.
Five out of the six cases of pleural cancer occurred 
more than 20 years since starting employment (table 
3) yielding a 71% increased risk (95% CI 0.71-4.11). 
The increase in brain cancer mortality was confined 
to the shortest latency category and was not affected 
by duration of employment. 
Among hematopoietic neoplasms, AML and 
CLL showed a 55% and 78% excess after 20 years 
since first employment. All cases of AML occurred 
in workers with 20 or more years of latency. 
No clear pattern by duration of employment was 
observed for most cancer deaths with three possible 
exceptions: 3 AML deaths yielded a two-fold in-
creased risk in workers employed 20 or more years; 
in the same category of duration of employment 
excess risks were observed for LL (5 deaths, SMR 
2.59 95% CI 1.08-6.22, 4 of them were CLL) and 
pleural cancer (4 deaths, SMR 2.36 95% CI 0.89-
6.29).
Analysis by period of employment (≤1969,1970-
1979, ≥1980, Supplementary table 1) did not show 
any particular trend for most of the relevant cause 
of deaths.
Table 3 - Standardized mortality ratios (SMR) and 95% Confidence Intervals (CI) for selected cancer causes by time since 
first employment
                        Time since first employment (years)
 <10        10-19        20 +
Cause of death Deaths SMR (95%CI) Deaths SMR (95%CI) Deaths SMR (95%CI)
All cancers 19 0.68 (0.43-1.07) 61 0.90 (0.71-1.17) 374 0.87 (0.79-0.97)
Stomach  1 0.31 (0.04-2.20) 10 1.29 (0.69-2.39) 30 0.81 (0.57-1.16)
Colon 0 - 4 3.30 (0.45-3.23) 24 0.93 (0.62-1.38)
Rectum 0 - 1 1.71 (0.08-4.15) 12 1.09 (0.62-1.92)
Liver 0 - 2 0.48 (0.12-1.93) 28 0.77 (0.53-1.12)
Pancreas 0 - 2 0.75 (0.19-3.01) 20 1.05 (0.68-1.63)
Lung 8 1.07 (0.53-2.13) 21 1.00 (0.65-1.53) 110 0.82 (0.68-0.99)
Pleural 0 - 1 2.49 (0.35-17.7) 5 1.71 (0.71-4.11)
Skin 0 - 0 - 3 0.71 (0.23-2.21)
Prostate 0 - 1 0.56 (0.08-3.98) 19 0.80 (0.51-1.25)
Bladder 0 - 2 1.05 (0.26-4.20) 15 090 (0.54-1.49)
Brain 4 4.28 (1.61-11.4) 2 1.13 (0.28-4.54) 8 1.17 (0.59-2.35)
Lymphoma  1 0.56 (0.08-3.94)) 2 0.87 (0.22-3.47) 14 1.28 (0.76-2.17)
   HD  0 - 2 2.51 (0.62-10.0) 2 1.49 (0.37-5.96)
   NHL  1 1.02  (0.14-7.21) 0 - 12 1.25 (0.71-2.21)
Leukemia 1 0.64  (0.09-4.54) 4 1.81  (0.68-4.82) 16 1.44 (0.88-2.36)
   Myeloid leukemia 0  1 1.07  (0.15-7.62) 7 1.49 (0.71-3.12)
   AML 0  0  4 1.55 (0.58-4.12)
   CML 0 - 1  2.39 (0.34-17.0) 2 1.27 (0.32-5.05)
Lymphatic leukemia 0 - 1  1.85 (0.26-13.1) 7 1.98  (0.94-4.15)
   CLL 0 - 1 1.87  (0.26-13.3) 5 1.78  (0.74-4.28)
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discussion
In our mortality study of a pooled cohort of 
Italian oil refinery workers followed-up for about 
50 years, we observed an increased mortality from 
brain, pleural and some hematopoietic cancers.
The observed increased risk for brain cancer was 
concentrated among subjects with the shortest time 
since first employment and no clear pattern by dura-
tion of employment was observed. 
An increased risk for pleural cancer was observed 
in the whole cohort, suggesting a possible past as-
bestos exposure. Most cases occurred in subjects 
with duration of employment and latency longer 
than 20 years. These data are consistent with some 
previous epidemiological studies conducted among 
petrochemical workers in the US (20), Canada (13) 
and Italy (15), supporting the hypothesis of a sig-
nificant asbestos exposure in such industrial set-
ting.
As regard skin cancer, we are aware that, because 
of the low fatality rate of such tumors, mortality 
studies are not the best tool to detect a small (if ex-
isting) increased risk. However we find a decreased 
skin cancer mortality (-45%) based on 3 cases only.
Finally, focusing on lymphoemopoietic cancers, 
in the whole cohort a modest increased risk was 
found for myeloid leukemia and an 81% increased 
mortality was observed for LL. All AML and seven 
out of 8 cases of LL occurred after 20 years of la-
tency. Both AML and LL showed a near doubled 
increased risk among workers with the longest du-
ration of employment (≥20 years).
Although the small number of the observed 
events, limits the interpretation of our findings, our 
results are consistent with the current epidemiologi-
cal evidence extending to lymphatic leukemia, and 
particularly CLL, the spectrum of hematological 
malignancies associated with occupational exposure 
to benzene (10, 11, 14, 16, 17, 21). 
Table 4 - Standardized mortality ratios and 95% Confidence Interval  (CI) for selected cancer causes by duration of employ-
ment
                     Duration of employment (years)
 <10        10-19        20 +
Cause of death Deaths SMR (95%CI) Deaths SMR (95%CI) Deaths SMR (95%CI)
All cancers 124 0.80 (0.67-0.95) 123 0.87 (0.73-1.05) 207 0.91 (0.80-1.05)
Stomach 11 0.67 (0.37-1.21) 11 0.77 (0.42-1.38) 19 1.10 (0.70-1.71)
Colon  9 1.04 (0.54-2.00) 5 0.63 (0.26-1.52) 14 0.91 (0.59-1.68)
Rectum 3 0.73 (0.24-2.26) 5 1.32 (0.55-3.17) 5 0.89 (0.37-2.15)
Liver 3 0.27 (0.09-0.85) 8 0.79 (0.40-1.58) 19 0.90 (0.58-1.42)
Pancreas 3 0.48 (0.15-1.50) 5 0.84 (0.35-2.02) 14 1.34 (0.79-2.26)
Lung 43 0.91 (0.68-1.23) 39 0.89(0.65-1.22) 57 0.80 (0.61-1.03)
Pleural 2 1.55 (0.39-6.20) 0 - 4 2.36 (0.89-6.29)
Skin 0 - 2 1.43 (0.36-5.73) 1 0.44 (0.06-3.17)
Prostate 7 0.98 (0.47-2.06) 3 0.42 (0.13-1.29) 10 0.81 (0.44-1.50)
Bladder 5 0.91 (0.38-2.19) 7 1.34 (0.64-2.81) 5 0.56 (0.23-1.33)
Brain 7 1.99 (0.95-4.18) 2 0.80 (0.20-3.21) 5 1.42 (0.60-3.43)
Lymphoma  6 1.07  (0.48-2.38) 4 1.14 (0.43-3.03) 7 1.18  (0.56-2.48)
   HD  2 1.15  (0.29-4.58) 2 3.05 (0.76-12.2) 0 -
   NHL  4 1.04  (0.39-2.76) 2 0.70 (0.17-2.80) 7 1.31  (0.62-2.74)
Leukemia 7 1.32  (0.63-2.78) 3 0.83 (0.27-2.57) 11 1.85  (1.03-3.34)
Myeloid leukemia 3 1.37  (0.44-4.25) 0 - 5 1.98  (0.82-4.75)
    AML 1 0.95  (0.13-6.73) 0 - 3 2.05  (0.66-6.36)
    CML 2 2.30 (0.57-9.19) 0 - 1 1.34 (0.17-8.80)
Lymphatic leukemia 1 0.72  (0.10-5.12) 2 1.81 (0.45-7.23) 5 2.59 (1.08-6.22)
    CLL 1 0.78  (0.11-5.56) 1 1.16 (0.16-8.24) 4 2.58 (0.97-6.87)
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The meta-analysis of occupational cohorts by 
Vlaanderen et al supported the evidence of an asso-
ciation between benzene exposure and MM, ALL, 
and CLL (21, 22). We did not observe increased 
risk for MM but we did for lymphatic leukemia, 
although not statistically significant. Notably the 
most prominent increase in LL was among work-
ers with the longest duration of employment (≥20 
years), the same subgroup with a doubled risk of 
AML (see table 4). For this purpose it is important 
to underline that, as stated by Vlaanderen and col-
laborators, the power of detecting AML increased 
risk (a well-established benzene exposure related 
effect) is a valuable indicator of good methodologi-
cal quality for studies investigating benzene health 
effects (21). 
We did not found increased risk for CML con-
cordantly with most recent meta-estimates (10, 19, 
20, 22). 
The high proportion of successful vital status as-
certainment of cohort members, the very low num-
ber of missing causes of death, and the almost 50 
years of follow-up (49 years) are the major strengths 
of our study. Being more prolonged than most pub-
lished epidemiological studies, our mortality follow-
up study allowed to properly investigate risk of long 
latency diseases.
The main limitation is the lack of information on 
the job and the exposures of the individual cohort 
members. Only date of hiring and ceasing employ-
ment were available; we calculated duration of em-
ployment as a proxy for exposure. In addition, we 
could not formally investigate the role of benzene 
exposure due to the lack of quantitative data. Scanty 
environmental measurements were available only in 
two plants, Milano and Cagliari, for a limited time 
period and very few departments. In the Milano 
plant, environmental data (58 samples) were collect-
ed in 1984 and 1985 in the Production and Moving 
departments, where 28% and 41% of the samples 
respectively, showed benzene air levels above 1 ppm 
(the recommended European occupational exposure 
limit).
In the Cagliari plant, 118 samples were collected 
in more recent years (1988, 1993, 1996 and 1998). 
Most measurements in 1988 were below 1 ppm, and 
measurements collected in the ’90 revealed benzene 
levels always below 1 ppm (and below 0.5 ppm in 
98% of samples in 1998). 
These data do not allow to estimate benzene ex-
posure over the long study period, but they docu-
ment the decline in benzene exposure over recent 
decades: benzene levels were most likely higher in 
the past, when cohort members began their employ-
ment at the oil refineries. 
Death certificates are not the most accurate di-
agnostic tool for lympho-hematopoietic neoplasms; 
due to the long survival of patients affected by sev-
eral subtypes, and particularly CLL and HL, risk 
can be substantially underestimated when using 
mortality data in respect to incidence data (14, 19). 
There are several potential time-related con-
founders in occupational cohort studies, summa-
rized as the healthy worker effect (HWE) (4). In 
our study population lower mortality rates for circu-
latory, and pulmonary diseases suggest that HWE 
actually occurred. Moreover, HWE increases with 
duration of employment because of a self-selection 
of workers with longest employment duration , 
also called “healthy survivor effect”. We observed 
the highest risk of leukemia in the subgroup with 
the longest duration of employment, an excess that 
might have been even more pronounced in the ab-
sence of HWE. 
No information about smoking habits were avail-
able for our workers. Smoking is a well-established 
risk factor for several cancer sites including hemat-
opoietic neoplasms (9). However, lung cancer risk 
(the most frequent tobacco-related cancer), as well 
as non-neoplastic respiratory and circulatory disease 
mortality, had decreased in our cohort, suggesting 
smoking as an implausible confounder in our study. 
The decreased mortality from lung cancer in our co-
hort might have been a beneficial outcome of the no 
smoking policy introduced in these plants for safety 
purposes, which might have contributed to dimin-
ish smoking among cohort members in respect to 
the general population. 
In conclusion, our results are consistent with the 
previously reported excess mortality from pleural 
and hematopoietic malignancies among oil refinery 
workers. In particular, they provide support to the 
hypothesis of an increased risk  of hematopoietic 
diseases other than AML (8). 
bonzini et al10
But larger studies supported by an accurate expo-
sure assessment are warranted to properly identify 
a causative role of benzene, especially at the current 
very low exposure levels.
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